SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-192827
Filing Date
2019-07-12
Accepted
2019-07-12 08:30:32
Documents
5
Period of Report
2019-07-11
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d775689d8k.htm 8-K 27225
2 EX-99.1 d775689dex991.htm EX-99.1 8507
3 EX-99.2 d775689dex992.htm EX-99.2 8911
4 GRAPHIC g775689g25x04.jpg GRAPHIC 5445
5 GRAPHIC g775689horizon.jpg GRAPHIC 6843
  Complete submission text file 0001193125-19-192827.txt   63314
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 19952109
SIC: 2834 Pharmaceutical Preparations